Anofi - Net Worth and Insider Trading

Anofi Net Worth

The estimated net worth of Anofi is at least $6.1 Billion dollars as of 2024-09-20. Anofi is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 10,554,134 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $2.9 Billion. Anofi is the 10% Owner of Translate Bio Inc and owns about 75,668,031 shares of Translate Bio Inc (TBIO) stock worth over $2.8 Billion. Anofi is also the 10% Owner of Regeneron Pharmaceuticals Inc and owns about 279,766 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $322 Million. Besides these, Anofi also holds Icosavax Inc (ICVX) , Voyager Therapeutics Inc (VYGR) , Inozyme Pharma Inc (INZY) , Fulcrum Therapeutics Inc (FULC) , MyoKardia Inc (MYOK) . Details can be seen in Anofi 's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anofi has not made any transactions after 2021-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Anofi

Anofi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anofi owns 11 companies in total, including Inozyme Pharma Inc (INZY) , Regeneron Pharmaceuticals Inc (REGN) , and Fulcrum Therapeutics Inc (FULC) among others .

Click here to see the complete history of Anofi ’s form 4 insider trades.

Insider Ownership Summary of Anofi

Ticker	Comapny	Transaction Date	Type of Owner
INZY	Inozyme Pharma Inc	2020-07-28	10 percent owner
REGN	Regeneron Pharmaceuticals Inc	2020-06-09	10 percent owner
FULC	Fulcrum Therapeutics Inc	2019-07-22	10 percent owner
		2019-02-13	10 percent owner
		2017-05-31	10 percent owner
		2015-11-16	10 percent owner
		2014-05-07	10 percent owner
		2014-02-04	10 percent owner
		2013-11-06	10 percent owner
		2012-08-11	10 percent owner
		2021-08-02	10 percent owner

Anofi Latest Holdings Summary

Anofi currently owns a total of 8 stocks. Among these stocks, Anofi owns 10,554,134 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 31, 2017, with a value of $2.9 Billion and a weighting of 47.54%. Anofi owns 75,668,031 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $2.8 Billion and a weighting of 46.09%. Anofi also owns 279,766 shares of Regeneron Pharmaceuticals Inc (REGN) as of June 9, 2020, with a value of $322 Million and a weighting of 5.25%. The other 5 stocks Icosavax Inc (ICVX) , Voyager Therapeutics Inc (VYGR) , Inozyme Pharma Inc (INZY) , Fulcrum Therapeutics Inc (FULC) , MyoKardia Inc (MYOK) have a combined weighting of 1.12% among all his current holdings.

Latest Holdings of Anofi

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ALNY	Alnylam Pharmaceuticals Inc	2017-05-31	10,554,134	276.33	2,916,423,848
TBIO	Translate Bio Inc	2021-09-14	75,668,031	37.36	2,826,957,638
REGN	Regeneron Pharmaceuticals Inc	2020-06-09	279,766	1,150.19	321,784,056
ICVX	Icosavax Inc	2021-08-02	3,155,169	15.31	48,305,637
VYGR	Voyager Therapeutics Inc	2015-11-16	2,477,941	6.32	15,660,587
INZY	Inozyme Pharma Inc	2020-07-28	520,125	5.79	3,011,524
FULC	Fulcrum Therapeutics Inc	2019-07-22	558,035	3.46	1,928,011
MYOK	MyoKardia Inc	2019-02-13	0	224.91	0

Holding Weightings of Anofi

Anofi Form 4 Trading Tracker

According to the SEC Form 4 filings, Anofi has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the acquisition of 297,501 shares on May 31, 2017, which cost Anofi around $21 Million.

According to the SEC Form 4 filings, Anofi has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Translate Bio Inc is the acquisition of 71,983,597 shares on September 14, 2021, which cost Anofi around $2.7 Billion.

According to the SEC Form 4 filings, Anofi has made a total of 3 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 120,234 shares on June 9, 2020, which brought Anofi around $72 Million.

More details on Anofi 's insider transactions can be found in the Insider Trading History of Anofi table.

Insider Trading History of Anofi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anofi Trading Performance

GuruFocus tracks the stock performance after each of Anofi 's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anofi is -0.79%. GuruFocus also compares Anofi 's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anofi within 3 months outperforms 10 times out of 22 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anofi 's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anofi

Average Return

Average return per transaction

Outperforming Transactions

9 out of 22 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.01
Relative Return to S&P 500(%)	4.28

Anofi Ownership Network

Ownership Network List of Anofi

No Data

Ownership Network Relation of Anofi

Anofi Owned Company Details

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Anofi is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Regeneron Pharmaceuticals Inc do?

Who are the key executives at Regeneron Pharmaceuticals Inc?

Anofi is the 10 percent owner of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .

Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 9,914 shares made by Marion Mccourt , a net sale of 1,500 shares made by Arthur F Ryan , and a net sale of 9,158 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 36,273 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 36,273 shares. During the past 18 months, 326,467 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 326,467 shares.

Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

What does Fulcrum Therapeutics Inc do?

Who are the key executives at Fulcrum Therapeutics Inc?

Anofi is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .

Fulcrum Therapeutics Inc (FULC) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fulcrum Therapeutics Inc Insider Transactions

No Available Data

What does MyoKardia Inc do?

Who are the key executives at MyoKardia Inc?

Anofi is the 10 percent owner of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .

MyoKardia Inc (MYOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

MyoKardia Inc Insider Transactions

No Available Data

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Anofi is the 10 percent owner of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 60,146 shares made by Yvonne Greenstreet , a net sale of 14,598 shares made by Pushkal Garg , and a net sale of 6,616 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 135,278 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 135,278 shares. During the past 18 months, 269,382 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 269,382 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

What does Voyager Therapeutics Inc do?

Who are the key executives at Voyager Therapeutics Inc?

Anofi is the 10 percent owner of Voyager Therapeutics Inc. Other key executives at Voyager Therapeutics Inc include Chief Operating Officer Robin Swartz , Chief Scientific Officer Todd Alfred Carter , and Chief Financial Officer Peter P. Pfreundschuh .

Voyager Therapeutics Inc (VYGR) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 21,233 shares made by Todd Alfred Carter , a net sale of 9,125 shares made by Robin Swartz , and a net sale of 32,585 shares made by Alfred Sandrock .

In summary, during the past 3 months, insiders sold 0 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 80,274 shares of Voyager Therapeutics Inc (VYGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,274 shares.

Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voyager Therapeutics Inc Insider Transactions

No Available Data

What does SCYNEXIS Inc do?

Who are the key executives at SCYNEXIS Inc?

Anofi is the 10 percent owner of SCYNEXIS Inc. Other key executives at SCYNEXIS Inc include Chief Medical Officer Gonzalez David Angulo , Chief Financial Officer Ivor Macleod , and General Counsel Scott Sukenick .

SCYNEXIS Inc (SCYX) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in SCYNEXIS Inc (SCYX). Other recent insider transactions involving SCYNEXIS Inc (SCYX) include a net purchase of 20,000 shares made by Gonzalez David Angulo ,

In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

SCYNEXIS Inc Insider Transactions

No Available Data

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Anofi is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and Chief Operating Officer Joseph P Hagan .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Anofi is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 13,800 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 2,271,499 shares of GlycoMimetics Inc (GLYC) in total and bought 305,000 shares, with a net sale of 1,966,499 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 431,403 shares were bought by its insiders, resulting in a net sale of 1,843,796 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Anofi is the 10 percent owner of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Icosavax Inc do?

Who are the key executives at Icosavax Inc?

Anofi is the 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Business Officer Cassia Cearley , and Chief Medical Officer Niranjan Kanesa-thasan .

Icosavax Inc (ICVX) Insider Trades Summary

Over the past 18 months, Anofi made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 193,993 shares made by Adam K. Simpson , a net sale of 28,581 shares made by Cassia Cearley , and a net sale of 36,799 shares made by Douglas Holtzman .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 292,829 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 292,829 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Icosavax Inc Insider Transactions

No Available Data

Anofi Mailing Address

Above is the net worth, insider trading, and ownership report for Anofi . You might contact Anofi via mailing address: 46 Avenue De La Grande Armee, Paris I0 75017.

Discussions on Anofi

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.